The OC-Sensor™ has been the subject of extensive publications validating its No.1 position in the market

Bibliographic References - OC-Sensor™ System

2021

Bailey, J.A., Ibrahim, H., Bunce, J. et al. 
Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population. 
Tech Coloproctol. 2021. https://doi.org/10.1007/s10151-021-02466-z

Njor, S.H., Andersen, B., Friis-Hansen, L., de Haas, N., et al.
The optimal cut-off value in fit-based colorectal cancer screening: An observational study.
Cancer Med. 2021; 10: 1872-1879. https://doi.org/10.1002/cam4.3761

Piggott, C., Shugaa, Z. & Benton, S.
Independent internal quality control (IQC) for faecal immunochemical tests (FIT) for haemoglobin: use of FIT manufacturers’ IQC for other FIT systems.
Clinical Chemistry and Laboratory Medicine (CCLM). 2021; 59(2), e41-e43 https://doi.org/10.1515/cclm-2020-0286

Idos, G.E., Bonner, J.D., Haghighat, S., et al.
Bridging the Gap: Patient Navigation Increases Colonoscopy Follow-up After Abnormal FIT. 
Clin Transl Gastroenterol. 2021; 12(2):e00307. https://doi.org/10.14309/ctg.0000000000000307

Maclean, W., Limb, C., Mackenzie, P., Whyte, M.B., Benton, S.C., et al.
Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Colorectal Dis.2021; 23: 1622-1629. https://doi.org/10.1111/codi.15408

Tinmouth, J., Dong, S, Stogios, C., Rabeneck, L., et al.
Estimating the Backlog of Colonoscopy due to Coronavirus Disease 2019 and Comparing Strategies to Recover in Ontario, Canada,
Gastroenterology. 2021; 160(4), 1400-1402.e1. https://doi.org/10.1053/j.gastro.2020.11.048

Chapman, C.J., Banerjea, A., Humes, D.J., et al
"Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer" Clinical Chemistry and Laboratory Medicine (CCLM) 2021; 59(4) 721-728. https://doi.org/10.1515/cclm-2020-1170

Nwankwo, E. C., Jr, Lines, J., Trehan, S., Marsh, M., et aI.
Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test. 
Cureus. 2021; 13(4), e14382. https://doi.org/10.7759/cureus.14382

Randel, K.R., Schult, A.L., Botteri, E., et al.
Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial,
Gastroenterology. 2021; 160(4), 1085-1096.e5. https://doi.org/10.1053/j.gastro.2020.11.037.

Peng S, Hsu W, Wang Y, et al
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
Gut 2021;70:1318-1324. http://dx.doi.org/10.1136/gutjnl-2020-320761

Jung Y, Im E, Lee J, Lee H, Moon C.
Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity. 
Journal of Personalized Medicine. 2021; 11(6):497. https://doi.org/10.3390/jpm11060497

Pilonis, N.D., Bugajski, M., Wieszczy, P., et al.
Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Gastroenterology,2021; 160(4), 1097-1105, https://doi.org/10.1053/j.gastro.2020.11.049.

2020

Gruner, Laura Fiona et al.
“The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing.” 
Deutsches Arzteblatt international vol.2020; 117(25), 423-430. https://doi.org/10.3238/arztebl.2020.0423

K Sandhu, R Ayling, S Naik,
P285 Is faecal immunochemical test a suitable alternative to faecal calprotectin in children?
 Journal of Crohn's and Colitis. 2020; 14(1), S294–S295

 Georgios Tsapournas, Per M. Hellström, Yang Cao & Louise I. Olsson.
Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. 
Scandinavian Journal of Gastroenterology.2020; 55:2, 184-192. https://doi.org/10.1080/00365521.2019.1708965

 Masi AC, Koo S, Lamb CA, et al.
Using faecal immunochemical test (FIT) undertaken in a national screening programme for large-scale gut microbiota analysis.
Gut. 2021;70:429-431. http://dx.doi.org/10.1136/gutjnl-2020-321594

Mattar, R et al.
Diagnostic accuracy of one sample or two samples quantitative fecal immunochemical tests for intestinal neoplasia detection.
Arguivos de Gastroenterologia [online]. 2020; 57(03), 316-322. https://doi.org/10.1590/S0004-2803.202000000-58  

Pin-Vieito N, Iglesias MJ, Remedios D, et al.
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. 
World J Gastroenterol. 2020; 26(1):70–85. https://dx.doi.org/10.3748/wjg.v26.i1.70

Duran-Sanchon S, Moreno L, Gómez-Matas J, et al.
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test–Based Screening for Colorectal Cancer.
Clinical Gastroenterology and Hepatology, 2020, https://doi.org/10.1016/j.cgh.2020.02.043

Tomaszewski M, Sanders D, Enns RA, et al.
A137 COLONOSCOPY RELATED ADVERSE EVENTS IN A POPULATION-BASED COLON SCREENING PROGRAM.
Journal of the Canadian Association of Gastroenterology, Volume 3, Issue Supplement_1, 2020, 158–159, https://doi.org/10.1093/jcag/gwz047.136

Rodriguez-Alonso L, Rodriguez-Moranta F, Ruiz-Cerulla A, et al.
The use of faecal immunochemical testing in the decision-making process for the endoscopic investigation of iron deficiency anaemia, 
Clinical Chemistry and Laboratory Medicine (CCLM), 58(2), 232-239, https://doi.org/10.1515/cclm-2019-0203

Gruner LF, Hoffmeister M, Ludwig L, et al.
Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc 2020; 9(4):e16413, DOI: 10.2196/16413

Digby J, Cleary S, Gray, L, et al.
Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
United European Gastroenterology Journal, https://doi.org/10.1177/2050640620913674

Stidham R, Enchakalody B, Waljee A, et al.
P158 Semi-automated detection of qualitative features of Crohn’s disease activity found on CT-enterography using machine learning.
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, 2020, S217–S218, https://doi.org/10.1093/ecco-jcc/jjz203.287

Ykema B, Rigter L, Spaander M, et al.
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors. 
J. Clin. Med. 2020, 9(190). https://doi.org/10.3390/jcm9010190

Mas-Lloret, J., Obón-Santacana, M., Ibáñez-Sanz, G, et al. 
Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample. 
Sci Data 2020; 7, 92, https://doi.org/10.1038/s41597-020-0427-5

 

2019

Lee W, Ryoo N, Suh HS, Jeon CH, et al.
Urinalysis and Routine Microscopy Subcommittee, Korean Association of External Quality Assessment Service. Improvement in External Quality Assessment Results for Qualitative Fecal Immunochemical Tests in Korea After Feedback to Manufacturers. 
Ann Lab Med. 2019 ;39(6):584-586.   https://doi.org/10.3343/alm.2019.39.6.584

Kaalby L, Rasmussen M, Zimmermann-Nielsen E, et al.
Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program. 
Clin Epidemiol. 2019;11:659–667, https://doi.org/10.2147/CLEP.S206873

Moosavi S, Gentile L, Gondara L, et al.
Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer, 
Journal of the Canadian Association of Gastroenterology, ,gwz027, https://doi.org/10.1093/jcag/gwz027

Park CH, Jung YS, Kim NH, et al. 
Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia. 
Sci Rep 2019; 9, 9824 . https://doi.org/10.1038/s41598-019-44490-y

Yen AM‐F, Wang S‐T, Feng, et al.
The association between fecal hemoglobin concentration and oral potentially malignant disorders. 
Oral Dis. 2019; 25: 108– 116. https://doi.org/10.1111/odi.12978

 

Hiraoka S, Takashima S, Inokuchi T, et al.
The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.
Intest Res. 2019; 17(2):202–209. https://doi.org/10.5217/ir.2018.00086

Komor MA, Bosch LJ, Coupé VM, et al.
Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression.
J. Pathol., 2019 250: 288-298. https://doi.org/10.1002/path.5369

Peng, S., Chiu, H., Jen, H. et al. 
Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees. 
BMC Med Inform Decis Mak 2019; 19, 94. https://doi.org/10.1186/s12911-019-0812-1

Mole G, Withington J, Logan R.
From FOBt to FIT: making it work for patients and populations.
 Clin Med (Lond). 2019; 19(3):196–199. https://doi.org/10.7861/clinmedicine.19-3-196

Ruggli, M., Stebler, D., Gasteiger, M. et al. 
Experience with a colorectal cancer campaign in Swiss pharmacies. 
Int J Clin Pharm 2019; 41, 1359–1364. https://doi.org/10.1007/s11096-019-00899-z

Vitellius, C., Laly, M., Banaszuk, A, et al. 
Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening. 
Eur J Epidemiol 2019; 34, 163–172. https://doi.org/10.1007/s10654-018-0471-z

Chapman C, Bunce J, Oliver S, et al.
Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2‐week‐wait pathway for colorectal cancer.
BJS Open, 2019; 3, 395-402. doi:10.1002/bjs5.50131

Gudra D, Shoaie S, Fridmanis D, et al.
A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies
Gut 2019;68:1723-1725.http://dx.doi.org/10.1136/gutjnl-2018-316225

Zhong GC, Sun WP, Wan L, et al.
Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis.
Gastrointestinal Endoscopy, 2019; 91(3) 684-697.e15, https://doi.org/10.1016/j.gie.2019.11.035.

John C.T. Wong, Han-Mo Chiu, Hyun-Soo Kim, et al.
Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
Gastrointestinal Endoscopy, 2019; 89(3) 607-613.e1, https://doi.org/10.1016/j.gie.2018.11.014.

Pin Vieito N, Zarraquiños S, Cubiella J, et al.
High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. 
World J Gastroenterol. 2019; 25(19):2383–2401.  https://dx.doi.org/10.3748/wjg.v25.i19.2383

Mowat C, Digby J, Strachan JA, et al. 
Low Sensitivity of Fecal Immunochemical Tests (FIT) for Detection of Sessile Serrated Adenomas/Polyps Confirmed Over Clinical Setting, Geography, and FIT System. 
Dig Dis Sci 2019; 64, 3024–3026 https://doi.org/10.1007/s10620-019-05661-z

Schreuders EH, Grobbee EJ,  Nieuwenburg SAV, et al.
Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study,
The Lancet Gastroenterology & Hepatology, 2019; 4(8), 622-631,  https://doi.org/10.1016/S2468-1253(19)30176-1.

de Klerk CM, Wieten E, Lansdorp-Vogelaar I, et al.
Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme,
The Lancet Gastroenterology & Hepatology, 2019; 4(2) 111-118 https://doi.org/10.1016/S2468-1253(18)30319-4

2018
  • Chen SLS, Hsu CY, Yen AMF, et al.
    Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity
    Cancer Epidemiol Biomarkers Prev June 1 2018 (27) (6) 704-709; https://doi.org/10.1158/1055-9965.EPI-17-0387

  • Allison JE, Fraser CG.
    The importance of comparing quantitative faecal immunochemical tests (FIT) before selecting one for a population-based colorectal cancer screening programme.
    J Lab Precis Med 2018; 3:7. http://dx.doi.org/10.21037/jlpm.2018.01.05

  • Robbins E, Wooldrage K, MacRae E, et al.
    OTU-029 Faecal immunochemical tests (FIT) for surveillance after screening and polypectomy: an accuracy and efficiency study
    Gut 2018;67:A222. http://dx.doi.org/10.1136/gutjnl-2018-BSGAbstracts.443

  • Pramual P, Sarakarn P, Kamsa-ard S, et al. (2018).
    Lack of Association between Red Meat Consumption and a Positive Fecal Immunochemical Colorectal Cancer Screening Test in Khon Kaen, Thailand: a Population- Based Randomized Controlled Trial. 
    Asian Pacific Journal of Cancer Prevention: APJCP, 19(1), 271–278. https://doi.org/10.22034/APJCP.2018.19.1.271

  • Cooper JA, Parsons N, Stinton C, et al.
    Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model.
    Br J Cancer. 2018 Jan;118(2):285-293. https://doi.org/10.1038/bjc.2017.375

  • Larsen MB, et al.
    Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
    Gastroenterology. 2018 Jul;155(1):99-106. https://doi.org/10.1053/j.gastro.2018.03.062

  • Hiraoka S, Inokuchi T, Nakarai A, et al.
    Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis.
    Gut Liver. 2018 Mar 15;12(2):142-148. https://doi.org/10.5009/gnl17013

  • Jung YS, Park CH, Kim NH, et al.
    Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    PLoS One. 2018 Jan 11;13(1):e0191125. https://doi.org/10.1371/journal.pone.0191125

  • Shin HY, Suh M, Choi KS, et al.
    Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
    BMC Cancer. 2018 Apr 2;18(1):365. https://doi.org/10.1186/s12885-018-4290-0

  • Osborne JM, Wilson C, Duncan A, et al.
    Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    BMC Public Health. 2017 Aug 1;18(1):81. https://doi.org/10.1186/s12889-017-4634-8

  • Pellat A, Deyra J, Romain Coriat, R, et al.
    Results of the national organised colorectal cancer screening program with FIT in Paris
    Scientific Reports, 2018 8(1), 4162. https://doi.org/10.1038/s41598-018-22481-9

  • Gies A, Cuk K, Schrotz-King, P, et al.
    Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening
    Gastroenterology 2018;154:93–104. https://doi.org/10.1053/j.gastro.2017.09.018

  • Carroll MR, John C, Mantio D, et al.
    An assessment of the effect of haemoglobin variants on detection by faecal immunochemical tests
    Annals of Clinical Biochemistry 2018; 0(0) 1–4. https://doi.org/10.1177/0004563218778716

  • Liles EG, Perrin N, Rosales AG, et al.
    Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study
    BMC Cancer 2018; 18:509. https://doi.org/10.1186/s12885-018-4402-x

  • Piggott C, John C, Bruce H, et al.
    Does the mass of sample loaded affect faecal haemoglobin concentration using the faecal immunochemical test?
    Annals of Clinical Biochemistry 2018; 0(0) 1–4. https://doi.org/10.1177/0004563218778701

  • van der Vlugt M, Grobbee EJ, Bossuyt PM, et al.
    Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program
    Clin Gastroenterol Hepatol. 2018; S1542-3565(18)30107-1. https://doi.org/10.1016/j.cgh.2018.01.037

  • van der Vlugt M, Grobbee EJ, Bossuyt PM, et al.
    Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    Gastroenterology 2017; 153:439–447. https://doi.org/10.1053/j.gastro.2017.05.004

  • Grobbee EJ, Schreuders EH, Hansen BE, et al.
    Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia
    Gastroenterology 2017; 153:1251–1259. https://doi.org/10.1053/j.gastro.2017.07.034
2017
  • Symonds EL, Cole SR, Bastin D, Fraser RJ, Young GP.
    Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements.
    J Med Screen. 2017 Dec;24(4):176-181.

  • Manuel Zorzi, Cesare Hassan, Giulia Capodaglio, Chiara Fedato, Adriana Montaguti, Anna Turrin, Alberto Rosano, Daniele Monetti, Carmen Stocco, Susanna Baracco, Francesca Russo, Alessandro Repici, Massimo Rugge
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test
    http://dx.doi.org/10.1136/gutjnl-2017-314753

  • Jacqueline Murphy, Stephen Halloran, Alastair Gray
    Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England
    http://dx.doi.org/10.1136/bmjopen-2017-017186

  • E MacRae, A Brenner, J Martin, S Pearson, C Piggott, H Bowyer, G Vart, C von Wagner, J Wardle, S Halloran, W Atkin
    Sensitivity Of Annual Faecal Immunochemical Tests For Haemoglobin (fit) For Detecting Advanced Neoplasia In Patients Undergoing Three-yearly Surveillance Colonoscopy – The Fit For Follow-up Study
    http://dx.doi.org/10.1136/gutjnl-2014-307263.42

  • Cubiella J, Digby J, Rodríguez-Alonso L, Vega P, Salve M, Díaz-Ondina M, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes HB, Rodriguez-Moranta F, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Garayoa A, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Steele RJ, Fraser CG.
    The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 May 15;140(10):2201-2211

  • Shi HY, Chan FKL, Chan AWH, Higashimori A, Kyaw M, Ching JYL, Luk AKC, Wong SH, Wu JCY, Sung JJY, Ng SC.
    Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.
    J Crohns Colitis. 2017 Sep 1;11(9):1071-1077

  • David J Gibson, Blathnaid Nolan, Joanna Rea, Maire Buckley, Gareth Horgan, Kieran Sheahan, Glen A Doherty, Diarmuid O’Donoghue, Hugh E Mulcahy, Alan Smith, Garret Cullen.
    A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening population
    http://dx.doi.org/10.1136/flgastro-2017-100869

  • Rapi S, Berardi M, Cellai F, Ciattini S, Chelazzi L, Ognibene A, Rubeca T
    Effects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin.
    Int J Biol Markers. 2017 Jul 24;32(3):e261-e266

  • Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ.
    Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    J Med Screen. 2017 Jun;24(2):62-68

  • Grazzini G, Ventura L, Rubeca T, Rapi S, Cellai F, Di Dia PP, Mallardi B, Mantellini P, Zappa M, Castiglione G.
    Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
    Eur J Cancer Prev. 2017 Jul;26(4):285-291

  • Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V
    False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.
    Eur J Cancer Prev. 2017 Sep;26(5):365-367

  • CJ Chapman, A Banerjea, O Ng, A Barke, A Duffin, K Dale, J Allen, RF Logan
    The “getting fit” project in nottingham: a comparison of haemoglobin levels as measured by oc sensor and hm jack in two week wait referrals.
    http://dx.doi.org/10.1136/gutjnl-2017-314472.171

  • Manuel Zorzi, Cesare Hassan, Giulia Capodaglio, Chiara Fedato, Adriana Montaguti, Anna Turrin, Alberto Rosano, Daniele Monetti, Carmen Stocco, Susanna Baracco, Francesca Russo, Alessandro Repici, Massimo Rugge
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test
    http://dx.doi.org/10.1136/gutjnl-2017-314753

  • Arana-Arri E, Idigoras I, Uranga B, Pérez R, Irurzun A, Gutiérrez-Ibarluzea I, Fraser CG, Portillo I
    Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    BMC Cancer. 2017 Aug 29;17(1):577

  • Grobbee EJ, Schreuders EH, Hansen BE, Bruno MJ, Lansdorp-Vogelaar I, Spaander MCW, Kuipers EJ.
    Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.
    Gastroenterology. 2017 Nov;153(5):1251-1259

  • Aniwan S1, Ratanachu-Ek T, Pongprasobchai S, Limsrivilai J, Praisontarangkul OA, Pisespongsa P, Mairiang P, Sangchan A, Sottisuporn J, Wisedopas N, Kullavanijaya P, Rerknimitr R.
    Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study.
    Clin Transl Gastroenterol. 2017 Aug 10;8(8):e113

  • van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.
    Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    Gastroenterology 2017; 153:439–447

  •  Grobbee EJ, Schreuders EH, Hansen BE, Bruno MJ, Lansdorp-Vogelaar, Spaander MCW, Kuipers EJ.
    Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia
    Gastroenterology 2017; 153:1251–1259
2016

  • Cooper J, Moss S, Smith S, Seaman H, Taylor-Phillips S, Parsons N and Halloran S. 2016
    FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test
    Colorectal Disease: July

  • Cubiella J, Catells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas A, Morillas J, Salas D, Quintero E.
    Correlation between adenoma detection rate in colonoscopy- and faecal immunochemical testing-based colorectal cancer screening programs
    United European Gastroenterology Journal 0(0) 1–6

  • Digby J, Fraser C, Carey F, Diament R, Balsitis M and Steele R.
    Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round
    J Med Screen 0(0) 1–7
    http://gut.bmj.com/content/early/2015/10/29/gutjnl-2015-310256.full

  • Grazzini, Grazia; Ventura, Leonardo; Rubeca, Tiziana; Rapi, Stefano; Cellai, Filippo; Di Dia, Pietro P.; Mallardi, Beatrice; Mantellini, Paola; Zappa, Marco; Castiglione, Guido. 2016
    Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
    European Journal of Cancer Prevention

  • Kato J, Hiraoka S, Nakarai A, Takashima S, Inokuchi T, Ichinose M
    Faecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival faecal calprotectin?
    Intest Res 2016;14(1):5-14
    http://dx.doi.org/10.5217/ir.2016.14.1.5

  • Moss S, Mathews C, Day TJ, Smith S, Halloran SP.
    A faecal immunochemical test for haemoglobin (FIT) markedly increased participation in a colorectal cancer screening pilot in England
    FIT_Pilot_Naedi_March_2015_-_Winner_of_Expert_Panel_Prize.pdf

  • Moss S, Mathews C, Day TJ, Smith S, Seamen HE, Snowball J, Halloran SP. 2016
    Increased uptake and improved outcomes of bowel cancer screening with a faecal  immunochemical test: results from a pilot study within the national screening programme in England.
    Gut 2016(0):1–14
    http://gut.bmj.com/content/early/2016/06/07/gutjnl-2015-310691.abstract

  • Wieten E, Schreuders E, Nieuwenburg S, Hansen B, Lansdorp-Vogelaar I, Kuipers E,  Bruno M, Manon C, Spaander M. 2016
    Effects of increasing screening age and fecal hemoglobin cut-off concentrations in a colorectal cancer screening program.
    Clin Gastroenterol Hepatol (Epub 2016 Aug 24).

2015
  • Auer R, Selby K, Bulliard JL, Nichita C, Dorta G, Ducros C and Cornuz J. 2015.
    Shared decision making in the colorectal cancer screening program in the canton of Vaud. (Article in French)
    Rev Med Suisse. Nov 25;11(496):2209-15.

  • Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G and Guittet L. 2015.
    Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
    Int J Cancer. 15;136(8):1827-34.
    http://dx.doi.org/10.1002/ijc.29187

  • Digby J, Fraser C, Carey F, Lang J, Stanners G and Steele R
    Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited
    J Med Screen 0(0) 1–5

  • Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, and Moreno V. 2015.
    Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain.
    Gastroenterology Research and Practice Volume 2015, Article ID 672410.
    http://dx.doi.org/10.1155/2015/672410

  • Mowat C, Digby J, Strachan JA, Wilson R, Carey FA, Fraser CG and Steele RJC. 2015.
    Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Gut 0:1-7.
    http://dx.doi.org/10.1136/gutjnl-2015-309579

  • Rapi S, Rubeca T and Fraser CG. 2015.
    How to improve the performances of Fecal Immunological Tests (FIT): Need for standardization of the sampling and pre-analytical phases and revision of the procedures for comparison of methods.
    Int J Biol Markers; 30(1): e127-e131.
    http://dx.doi.org/10.5301/jbm.5000093

  • Rubeca T, Cellai F, Confortini M, Fraser CG and Rapi S. 2015.
    Impact of preanalytical factors on fecal immunochemical tests: need for new strategies in comparison of methods.
    Int J Biol Markers; 30(3): e269-e274.
    http://dx.doi.org/10.5301/jbm.5000150

  • Santare D, Kojalo I, Huttunen T, Rikacovs S, Rucevskis P, Boka V and Leja M. 2015.
    Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    European Journal of Gastroenterology & Hepatology, 27:536-543.
    http://dx.doi.org/10.1097/MEG.0000000000000314

  • Stegeman I, van Doorn SC, Mundt MW, Mallant-Hent RC, Bongers E, Elferink MA, Fockens P, Stroobants AK, Bossuyt PM and Dekker E. 2015.
    Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Cancer Epidemiol. 2015; 39(3): 388-393.
    http://dx.doi.org/10.1016/j.canep.2015.03.012

  • Symonds E, Pedersen S, Cole S, Massolino J, Byrne D, Guy J, Backhouse P, Fraser R, La Pointe L, Young G.
    Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests
    Asian Pacific Journal of Cancer Prevention, Vol 16, 2015

  • van Hees F, Zauber AG, van Veldhuizen H, Heijnen MLA, Penning C, de Koning HJ, van Ballegooijen M and Lansdorp-Vogelaar I. 2015.
    The value of models in informing resource allocation in colorectal cancer screening – 1 the case of the Netherlands.
    Gut; 64(12): 1985-1997.
    http://dx.doi.org/10.1136/gutjnl-2015-309316

  • Wilson CJ, Flight IHK, Turnbull D, Gregory T, Cole SR, Young GP and Zajac IT. 2015.
    A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson et al. BMC Medical Informatics and Decision Making 15:25.
    http://dx.doi.org/10.1186/s12911-015-0147-5

  • Yueh-Hsia Chiu S, Chuang S, Li-Sheng Chen S et al.
    Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program
    Chiu SY-H, et al. Gut 2015;0:1–8.

2014
  • Bujanda L, Sarasqueta C, Lanas A, Quintero E, Cubiella J, Hernandez V, Morillas JD, Perez-Fernandez T, Salas D, Andreu M and others. 2014.
    Effect of Oral Anticoagulants on the Outcome of Faecal Immunochemical Test.
    Br J Cancer 110(5):1334-7.

  • Chiang T, Chuang S, Chen S, Chiu H, Yen A, Chiu S, Fann J, Chou C, Lee Y, Wu M, Chen H.
    Difference in Performance of Fecal Immunochemical Tests with the Same Hemoglobin Cutoff Concentration in a Nationwide Colorectal Cancer Screening Program
    Gastroenterology 2014;147:1317–1326

  • Digby J, McDonald P, Stachan JA, Libby G, Steele RJC and Fraser CG. 2014.
    Deprivation and faecal haemoglobin: implications for bowel cancer screening.
    J Med Screen. May 2014.
    http://dx.doi.org/10.1177/0969141314535388

  • Fraser CG, Rubeca T, Rapi S, Chen LS, Chen HH. 2014.
    Faecal Haemoglobin Concentrations Vary with Sex and Age, but Data Are Not Transferable across Geography for Colorectal Cancer Screening.
    Clin Chem Lab Med. 10.1515
    http://www.ncbi.nlm.nih.gov/pubmed/24637000

  • Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, de Castro L, Vega P and others. 2014.
    Faecal Immunochemical Test Accuracy in Average-Risk Colorectal Cancer Screening.
    World J Gastroenterol 20(4):1038-47.

  • Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. 2014.
    Multitarget Stool DNA Testing for Colorectal-Cancer Screening.
    N Engl J Med 370(14):1287-97.

  • Kapidzic A, J. Grobbee E, Hol L, H.C. van Roon A, J. van Vuuren A, Spijker W, Izelaar K, van Ballegooijen M, J. Kuipers E and E. van Leerdam M. 2014.
    Attendance and Yield Over Three Rounds of Population-Based Fecal Immunochemical Test Screening.
    Am J Gastroenterol; 109:1257-1264;
    http://dx.doi.org/10.1038/ajg.2014.168

  • Lee JK, Liles EG, Bent S, Levin TR, Corley DA. 2014.
    Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-Analysis.
    Ann Intern Med 160(3):171.

  • Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J. 2014.
    The Cost-Effectiveness of Immunochemical Tests for Colorectal Cancer Screening.
    Digestive and Liver Disease 46 (2014) 76-81.

  • McNamara D, Leen R, Seng-Lee C, Shearer N, Crotty P, Neary P, Walsh P, Boran G and O’Morain C. 2014.
    Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght–Trinity College colorectal cancer screening programme with the faecal immunological test.
    European Journal of Gastroenterology & Hepatology.

  • Mosen DM, Liles EG, Feldstein AC, Perrin N, Rosales AG, Keast E and Smith DH. 2014.
    Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT.
    European Journal of Cancer Prevention, 23:516-523.
    http://dx.doi.org/10.1097/CEJ.0000000000000084

    Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Díez-Fuentes ML and Abraira V. 2014.
    Equivalency of Fecal Immunochemical Tests and Colonoscopy in Familial Colorectal Cancer Screening.
    Gastroenterology;147(5):1021-1030.
    http://dx.doi.org/10.1053/j.gastro.2014.08.004

  • Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM. 2014.
    Combining Risk Factors with Faecal Immunochemical Test Outcome for Selecting Crc Screenees for Colonoscopy.
    Gut 63(3):466-71.

  • Turenhout S T, Oort F, Hulst R, Visscher A et al.
    Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
    BMC Gastroenterology (2014) 14:217

  • Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, Fedato C, Saugo M, and Dei Tos AP. 2014.
    Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Gut 10.1136/gutjnl-2014-307508.

  • Zubero MB, Arana-Arri E, Pijoan JI, Portillo I, Idigoras I, Lopez-Urrutia A, Samper A, Uranga B, Rodriguez C, Bujanda L. 2014.
    Population-Based Colorectal Cancer Screening: Comparison of Two Fecal Occult Blood Test.
    Front Pharmacol 4:175

2013
  • Brenner H, Tao S. 2013.
    Superior Diagnostic Performance of Faecal Immunochemical Tests for Haemoglobin in a Head-to-Head Comparison with Guaiac Based Faecal Occult Blood Test among 2235 Participants of Screening Colonoscopy.
    Eur J Cancer 49(14):3049-54.

  • Bujanda L, Lanas A, Quintero E, Castells A, Sarasqueta C, Cubiella J, Hernandez V, Morillas JD, Perez-Fernandez T, Salas D and others. 2013.
    Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test.
    Mayo Clin Proc 88(7):683-9.

  • Chen LS, Yen AMF, Fraser CG, Chiu SYH, Fann JCY, Wang PE, Lin SC, Liao CS, Lee YC, Chiu HM and others. 2013.
    Impact of Faecal Haemoglobin Concentration on Colorectal Cancer Mortality and All-Cause Death.
    BMJ Open 3(11).

  • Chubak J, Bogart A, Fuller S, Laing SS, Green BB. 2013.
    Uptake and Positive Predictive Value of Fecal Occult Blood Tests: A Randomized Controlled Trial.
    Prev Med 57(5):671-8.

  • Digby J, Fraser CG, Carey FA, McDonald PJ, Strachan JA, Diament RH, Balsitis M, Steele RJ. 2013a.
    Faecal Haemoglobin Concentration Is Related to Severity of Colorectal Neoplasia.
    J Clin Pathol 66(5):415-9.

  • Digby J, McDonald PJ, Strachan JA, Libby G, Steele RJ, Fraser CG. 2013b.
    Use of a Faecal Immunochemical Test Narrows Current Gaps in Uptake for Sex, Age and Deprivation in a Bowel Cancer Screening Programme.
    J Med Screen 20(2):80-5.

  • Fujimura K, Kurita Y, Nishimura E, Yamaguchi J, Mori S, Satho H. 2013.
    Comparison Study of Automated Immunochemical Fecal Occult Blood Test Analyzer Performance.
    The Journal of Clinical Laboratory Insturments and Reagents 36(5):679-685.

  • Goede SL, van Roon AH, Reijerink JC, van Vuuren AJ, Lansdorp-Vogelaar I, Habbema JD, Kuipers EJ, van Leerdam ME, van Ballegooijen M. 2013.
    Cost-Effectiveness of One Versus Two Sample Faecal Immunochemical Testing for Colorectal Cancer Screening.
    Gut 62(5):727-34.

  • Guildford Medical Device Evaluation Centre 2013
    Evaluation of Quantitative Faecal Immunochemical Tests for Haemoglobin.

  • McDonald PJ, Digby J, Innes C, Strachan JA, Carey FA, Steele RJ, Fraser CG. 2013.
    Low Faecal Haemoglobin Concentration Potentially Rules out Significant Colorectal Disease.
    Colorectal Dis 15(3):e151-9.

  • Raginel T, Puvinel J, Ferrand O, Bouvier V, Levillain R, Ruiz A, Lantieri O, Launoy G, Guittet L. 2013.
    A Population-Based Comparison of Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening.
    Gastroenterology 144(5):918-25.

  • Senore C, Ederle A, Benazzato L, Arrigoni A, Silvani M, Fantin A, Fracchia M, Armaroli P, Segnan N. 2013.
    Offering People a Choice for Colorectal Cancer Screening.
    Gut 62(5):735-40.

  • van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje H, van der Togt AC, Habbema JD and others. 2013.
    Random Comparison of Repeated Faecal Immunochemical Testing at Different Intervals for Population-Based Colorectal Cancer Screening.
    Gut 62(3):409-15.

2012
  • de Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, Stegeman I, Kraaijenhagen RA, Fockens P, van Leerdam ME and others. 2012.
    Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia.
    Am J Gastroenterol 107(10):1570-8.

  • Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E. 2012.
    Lower Risk of Advanced Neoplasia among Patients with a Previous Negative Result from a Fecal Test for Colorectal Cancer.
    Gastroenterology 142(3):497-504.

  • Faivre J, Dancourt V, Denis B, Dorval E, Piette C, Perrin P, Bidan JM, Jard C, Jung S, Levillain R and others. 2012a.
    Comparison between a Guaiac and Three Immunochemical Faecal Occult Blood Tests in Screening for Colorectal Cancer.
    Eur J Cancer 48(16):2969-76.

  • Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S and others. 2012b.
    Positivity Rates and Performances of Immunochemical Faecal Occult Blood Tests at Different Cut-Off Levels within a Colorectal Cancer Screening Programme.
    Dig Liver Dis 44(8):700-4.

  • Grotta S, Segnan N, Paganin S, Dagnes B,Rosset R,Senore C.
    High Rate of Advanced Adenoma Detection in 4 Rounds of Colorectal Cancer Screening With the Fecal Immunochemical Test
    Clinical Gastroenterology and Hepatology 2012;10:633–638

  • Hol L, Kuipers EJ, van Ballegooijen M, van Vuuren AJ, Reijerink JC, Habbema DJ, van Leerdam ME. 2012.
    Uptake of Faecal Immunochemical Test Screening among Nonparticipants in a Flexible Sigmoidoscopy Screening Programme.
    Int J Cancer 130(9):2096-102.

  • Kovarova JT, Zavoral M, Zima T, Zak A, Kocna P, Kohout P, Granatova J, Vanickova Z, Vranova J, Suchanek S and others. 2012.
    Improvements in Colorectal Cancer Screening Programmes - Quantitative Immunochemical Faecal Occult Blood Testing - How to Set the Cut-Off for a Particular Population.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156(2):143-50.

  • McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG. 2012.
    Faecal Haemoglobin Concentrations by Gender and Age: Implications for Population-Based Screening for Colorectal Cancer.
    Clin Chem Lab Med 50(5):935-40.

  • Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, Andreu M, Carballo F, Morillas JD, Hernandez C and others. 2012.
    Colonoscopy Versus Fecal Immunochemical Testing in Colorectal-Cancer Screening.
    N Engl J Med 366(8):697-706.

  • Rozen P, Liphshitz I, Barchana M. 2012.
    Follow-up of Patients Undergoing Both Semiquantitated Immunochemical Fecal Occult Blood and Colonoscopy Examinations.
    Eur J Cancer Prev 21(3):247-53.

  • Terhaar sive Droste JS, van Turenhout ST, Oort FA, van der Hulst RW, Steeman VA, Coblijn U, van der Eem L, Duijkers R, Bouman AA, Meijer GA and others. 2012.
    Faecal Immunochemical Test Accuracy in Patients Referred for Surveillance Colonoscopy: A Multi-Centre Cohort Study.
    BMC Gastroenterol 12:94.

  • van Roon AH, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, Nagtzaam N, Reijerink JC, van der Togt AC, van Ballegooijen M and others. 2012.
    Are Fecal Immunochemical Test Characteristics Influenced by Sample Return Time?
    A Population-Based Colorectal Cancer Screening Trial.
    Am J Gastroenterol 107(1):99-107.

  • Van Roosbroeck S, Hoeck S, Van Hal G. 2012.
    Population-Based Screening for Colorectal Cancer Using an Immunochemical Faecal Occult Blood Test: A Comparison of Two Invitation Strategies.
    Cancer Epidemiol 36(5):e317-24.

  • van Turenhout ST, van Rossum LG, Oort FA, Laheij RJ, van Rijn AF, Terhaar sive Droste JS, Fockens P, van der Hulst RW, Bouman AA, Jansen JB and others. 2012.
    Similar Fecal Immunochemical Test Results in Screening and Referral Colorectal Cancer.
    World J Gastroenterol 18(38):5397-403.

  • Zorzi M, Baracco S, Fedato C. 2012.
    Limited Effect of Summer Warming on the Sensitivity of Colorectal Cancer Screening.
    Gut 61(1):162; author reply 162.

2011
  • Chen LS, Yen AM, Chiu SY, Liao CS, Chen HH. 2011.
    Baseline Faecal Occult Blood Concentration as a Predictor of Incident Colorectal Neoplasia: Longitudinal Follow-up of a Taiwanese Population-Based Colorectal Cancer Screening Cohort.
    Lancet Oncol 12(6):551-8.

  • Chiang TH, Lee YC, Tu CH, Chiu HM, Wu MS. 2011.
    Performance of the Immunochemical Fecal Occult Blood Test in Predicting Lesions in the Lower Gastrointestinal Tract.
    CMAJ 183(13):1474-81.

  • Guittet L, Bailly L, Bouvier V, Launoy G. 2011a.
    Indirect Comparison of Two Quantitative Immunochemical Faecal Occult Blood Tests in a Population with Average Colorectal Cancer Risk.
    J Med Screen 18(2):76-81.

  • Guittet L, Guillaume E, Bouvier V, Launoy G. 2011b.
    Seasonal Variations of Immunochemical and Gaiac Faecal Occult Blood Tests.
    Gut 60(3):423-4; author reply 424.

  • Guittet L, Guillaume E, Levillain R, Beley P, Tichet J, Lantieri O, Launoy G. 2011c.
    Analytical Comparison of Three Quantitative Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening.
    Cancer Epidemiol Biomarkers Prev 20(7):1492-501

  • Lee CS, O'Gorman P, Walsh P, Qasim A, McNamara D, O'Morain CA, Boran GP. 2011.
    Immunochemical Faecal Occult Blood Tests Have Superior Stability and Analytical Performance Characteristics over Guaiac-Based Tests in a Controlled in Vitro Study.
    J Clin Pathol 64(6):524-8.

  • Oort FA, van Turenhout ST, Coupe VM, van der Hulst RW, Wesdorp EI, Terhaar sive Droste JS, Larbi IB, Kanis SL, van Hengel E, Bouman AA and others. 2011.
    Double Sampling of a Faecal Immunochemical Test Is Not Superior to Single Sampling for Detection of Colorectal Neoplasia: A Colonoscopy Controlled Prospective Cohort Study.
    BMC Cancer 11:434.

  • Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I. 2011.
    Cost-Effectiveness of Mass Screening for Colorectal Cancer: Choice of Fecal Occult  Blood Test and Screening Strategy.
    Dis Colon Rectum 54(7):876-86.

  • Terhaar sive Droste JS, Oort FA, van der Hulst RW, van Heukelem HA, Loffeld RJ, van Turenhout ST, Ben Larbi I, Kanis SL, Neerincx M, Rakers M and others. 2011.
    Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers.
    Cancer Epidemiol Biomarkers Prev 20(2):272-80.

  • Van Hal G, Hoeck S, Van Roosbroeck S. 2011.
    Screening for Colorectal Cancer: Sense and Sensibilities.
    Eur J Cancer 47 Suppl 3:S156-63.

  • van Roon AH, Wilschut JA, Hol L, van Ballegooijen M, Reijerink JC, t Mannetje H, Kranenburg LJ, Biermann K, van Vuuren AJ, Francke J and others. 2011.
    Diagnostic Yield Improves with Collection of 2 Samples in Fecal Immunochemical Test Screening without Affecting Attendance.
    Clin Gastroenterol Hepatol 9(4):333-9.

  • van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, Jansen JB,
    Adang EM, Dekker E. 2011.
    Colorectal Cancer Screening Comparing No Screening, Immunochemical and Guaiac Fecal Occult Blood Tests: A Cost-Effectiveness Analysis.
    Int J Cancer 128(8):1908-17.

  • Wilschut JA, Habbema JD, van Leerdam ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ, van Ballegooijen M. 2011a.
    Fecal Occult Blood Testing When Colonoscopy Capacity Is Limited.
    J Natl Cancer Inst 103(23):1741-51.

  • Wilschut JA, Hol L, Dekker E, Jansen JB, Van Leerdam ME, Lansdorp-Vogelaar I, Kuipers EJ, Habbema JD, Van Ballegooijen M. 2011b.
    Cost-Effectiveness Analysis of a Quantitative Immunochemical Test for Colorectal Cancer Screening.
    Gastroenterology 141(5):1648-55 e1.

  • Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, Cazzola L, Montaguti A, Moretto T, Zappa M and others. 2011.
    High Sensitivity of Five Colorectal Screening Programmes with Faecal Immunochemical Test in the Veneto Region, Italy.
    Gut 60(7):944-9.
2010
  • Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB. 2010.
    Comparison of Guaiac and Immunological Fecal Occult Blood Tests in Colorectal Cancer Screening: The Patient Perspective.
    Scand J Gastroenterol 45(11):1345-9.

  • Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, Rubeca T, Visioli CB, Halloran SP. 2010.
    Influence of Seasonal Variations in Ambient Temperatures on Performance of Immunochemical Faecal Occult Blood Test for Colorectal Cancer Screening: Observational Study from the Florence District.
    Gut 59(11):1511-5.

  • Hazazi R, Rozen P, Leshno M, Levi Z, Samuel Z, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y. 2010.
    Can Patients at High Risk for Significant Colorectal Neoplasms and Having Normal Quantitative Faecal Occult Blood Test Postpone Elective Colonoscopy?
    Aliment Pharmacol Ther 31(4):523-33.

  • Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. 2010.
    Colorectal Cancer Screening Adherence Is Higher with Fecal Immunochemical Tests Than Guaiac-Based Fecal Occult Blood Tests: A Randomized, Controlled Trial.
    Prev Med 50(5-6):297-9.

  • Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ. 2010a.
    Screening for Colorectal Cancer: Comparison of Perceived Test Burden of Guaiac-Based Faecal Occult Blood Test, Faecal Immunochemical Test and Flexible Sigmoidoscopy.
    Eur J Cancer 46(11):2059-66.

  • Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. 2010b.
    Screening for Colorectal Cancer: Randomised Trial Comparing Guaiac-Based and Immunochemical Faecal Occult Blood Testing and Flexible Sigmoidoscopy.
    Gut 59(1):62-8.

  • Liedenbaum MH, de Vries AH, van Rijn AF, Dekker HM, Willemssen F, van Leerdam ME, van Marrewijk CJ, Fockens P, Bipat S, Bossuyt PMM and others. 2010.
    Ct Colonography with Limited Bowel Preparation for the Detection of Colorectal Neoplasia in an Fobt Positive Screening Population.
    Abdom Imaging 35(6):661-8.

  • Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S and others. 2010.
    Colonoscopy-Controlled Intra-Individual Comparisons to Screen Relevant Neoplasia: Faecal Immunochemical Test Vs. Guaiac-Based Faecal Occult Blood Test.
    Aliment Pharmacol Ther 31(3):432-9.

  • Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS. 2010.
    Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening.
    Am J Gastroenterol 105(9):2017-25.

  • Rozen P, Comaneshter D, Levi Z, Hazazi R, Vilkin A, Maoz E, Birkenfeld S, Niv Y. 2010.
    Cumulative Evaluation of a Quantitative Immunochemical Fecal Occult Blood Test to Determine Its Optimal Clinical Use.
    Cancer 116(9):2115-25.

2009
  • Gimeno-Garcia AZ, Quintero E, Nicolas-Perez D, Hernandez-Guerra M, Parra-Blanco A, Jimenez-Sosa A. 2009.
    Screening for Familial Colorectal Cancer with a Sensitive Immunochemical Fecal Occult Blood Test: A Pilot Study.
    Eur J Gastroenterol Hepatol 21(9):1062-7.

  • Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, Bortoli A, Castiglione G, Cazzola L, Confortini M and others. 2009.
    Immunochemical Faecal Occult Blood Test: Number of Samples and Positivity Cutoff. What Is the Best Strategy for Colorectal Cancer Screening?
    Br J Cancer 100(2):259-65.

  • Guildford Medical Evaluation Centre 2009
    - Evaluation Report: Immunochemical Faecal Occult Blood Tests.
    NHS Centre for Evidence-based Purchasing, UK.

  • Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink J, van der Togt ACM, Kuipers EJ, Habbema JDF, van Leerdam ME. 2009a.
    Screening for Colorectal Cancer: Random Comparison of Guaiac and Immunochemical Faecal Occult Blood Testing at Different Cut-Off Levels.
    Br J Cancer 100(7):1103-10.

  • Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y. 2009.
    Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, Nsaids, and Anticoagulants.
    Am J Gastroenterol 104(4):933-8.

  • Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y. 2009a.
    Identification of Colorectal Adenomas by a Quantitative Immunochemical Faecal Occult Blood Screening Test Depends on Adenoma Characteristics, Development Threshold Used and Number of Tests Performed.
    Aliment Pharmacol Ther 29(8):906-17.

  • Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y. 2009b.
    Quantitative Colonoscopic Evaluation of Relative Efficiencies of an Immunochemical Faecal Occult Blood Test and a Sensitive Guaiac Test for Detecting Significant Colorectal Neoplasms.
    Aliment Pharmacol Ther 29(4):450-7.

  • van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, Verbeek AL, Dekker E. 2009a.
    Cutoff Value Determines the Performance of a Semi-Quantitative Immunochemical Faecal Occult Blood Test in a Colorectal Cancer Screening Programme.
    Br J Cancer 101(8):1274-81.

  • van Rossum LG, van Rijn AF, van Munster IP, Jansen JB, Fockens P, Laheij RJ, Dekker E. 2009b.
    Earlier Stages of Colorectal Cancer Detected with Immunochemical Faecal Occult Blood Tests.
    Neth J Med 67(5):182-6.

  • van Rossum LG, van Rijn AF, van Oijen MG, Fockens P, Laheij RJ, Verbeek AL, Jansen JB, Dekker E. 2009c.
    False Negative Fecal Occult Blood Tests Due to Delayed Sample Return in Colorectal Cancer Screening.
    Int J Cancer 125(4):746-50.

  • van Rossum LGM, van Rijn AF, Laheij RJF, van Oijen MGH, Fockens P, Jansen J, Verbeek ALM, Dekker E. 2009d.
    Cutoff Value Determines the Performance of a Semi-Quantitative Immunochemical Faecal Occult Blood Test in a Colorectal Cancer Screening Programme.
    Br J Cancer 101(8):1274-81.

2008
  • Grazzini G, Ciatto S, Cislaghi C, Castiglione G, Falcone M, Mantellini P, Zappa M, Working Group of Regional Reference Centre for Oncological Screening of T. 2008.
    Cost Evaluation in a Colorectal Cancer Screening Programme by Faecal Occult Blood Test in the District of Florence.
    J Med Screen 15(4):175-81.

  • van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. 2008.
    Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population.
    Gastroenterology 135(1):82-90.

2007
  • Castiglione G, Visioli CB, Ciatto S, Grazzini G, Bonanomi AG, Rubeca T, Mantellini P, Zappa M. 2007.
    Sensitivity of Latex Agglutination Faecal Occult Blood Test in the Florence District Population-Based Colorectal Cancer Screening Programme.
    Br J Cancer 96(11):1750-4.

  • Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, Bonanomi AG, Confortini M, Zappa M. 2007.
    Association of Fobt-Assessed Faecal Hb Content with Colonic Lesions Detected in the Florence Screening Programme.
    Br J Cancer 96(2):218-21.

  • Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y. 2007.
    A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia.
    Ann Intern Med 146(4):244-55.

2006
  • Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y. 2006a.
    A Quantitative Immunochemical Faecal Occult Blood Test Is More Efficient for Detecting Significant Colorectal Neoplasia Than a Sensitive Guaiac Test.
    Aliment Pharmacol Ther 23(9):1359-64.

  • Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Niv Y. 2006b.
    Can Quantification of Faecal Occult Blood Predetermine the Need for Colonoscopy in Patients at Risk for Non-Syndromic Familial Colorectal Cancer?
    Aliment Pharmacol Ther 24(10):1475-81.

  • Nakazato M, Yamano HO, Matsuhita HO, Sato K, Fujita K, Yamanaka Y, et al. 2006.
    Immunogogic Fecal Occult Blood Test for Colorectal Cancer Screening.
    Japan Medical Association Journal 49:203-207.

  • Rozen P, Waked A, Vilkin A, Levi Z, Niv Y. 2006.
    Evaluation of a Desk Top Instrument for the Automated Development and Immunochemical Quantification of Fecal Occult Blood.
    Med Sci Monit 12(6):MT27-32.

  • Rubeca T, Rapi S, Confortini M, Brogioni M, Grazzini G, Zappa M, Puliti D, Castiglione G, Ciatto S. 2006.
    Evaluation of Diagnostic Accuracy of Screening by Fecal Occult Blood Testing (Fobt). Comparison of Fob Gold and Oc Sensor Assays in a Consecutive Prospective Screening Series.
    Int J Biol Markers 21(3):157-61.

2005
  • Federici A, Giorgi Rossi P, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. 2005.
    The Immunochemical Faecal Occult Blood Test Leads to Higher Compliance Than the Guaiac for Colorectal Cancer Screening Programmes: A Cluster Randomized Controlled Trial.
    J Med Screen 12(2):83-8.

  • Sohn DK, Jeong SY, Choi HS, Lim SB, Huh JM, Kim DH, Kim DY, Kim YH, Chang HJ, Jung
    KH and others. 2005.
    Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia.
    Cancer Res Treat 37(1):20-3.

  • Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y. 2005.
    Performance Characteristics and Evaluation of an Automated-Developed and Quantitative, Immunochemical, Fecal Occult Blood Screening Test.
    Am J Gastroenterol 100(11):2519-25.

2004
  • Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T and others. 2004.
    Colorectal Cancer Screening Programme by Faecal Occult Blood Test in Tuscany: First Round Results.
    Eur J Cancer Prev 13(1):19-26.

2002
  • Goto N, Michiko Fujimoto, Keiko Ito, Miki Tanaka, Sanae Ohara, Junko Makise, Yoshimaro
    Kijima. 2002.
    Basic Study of Oc-Sensor μ, a Compact Fully Automated Immunochemistry Analyzer for Fecal Occult Blood Tests.
    The Journal of Clinical Laboratory Insturments and Reagents 25(1):57-62.

  • Mizutani S, Fumitani M, Kanshiro E, Yamaguchi Y, Hayashi C, Noguchi S, Morimoto Y. 2002.
    Fundamental Evaluation of Fully Automated Fecal Occult Blood Analyzer "Oc-Sensor μ".
    Japanese Journal of Medicine and Pharmaceutical Science 47(5):769-773.

2001
  • Nakama H, Zhang B, Fukazawa K, Zhang X. 2001a.
    Comparisons of Cancer Detection Rate and Costs of One Cancer Detected among Different Age-Cohorts in Immunochemical Occult Blood Screening.
    J Cancer Res Clin Oncol 127(7):439-43.

  • Nakama H, Zhang B, Zhang X. 2001b.
    Evaluation of the Optimum Cut-Off Point in Immunochemical Occult Blood Testing in Screening for Colorectal Cancer.
    Eur J Cancer 37(3):398-401.

  • Nakama H, Zhang B, Zhang X, Fukazawa K. 2001c.
    Age-Related Cancer Detection Rate and Costs for One Cancer Detected in One Screening by Immunochemical Fecal Occult Blood Test.
    Dis Colon Rectum 44(11):1696-9.